Skip to main content
. 2017 Sep 7;40(5):1307–1314. doi: 10.3892/ijmm.2017.3124

Figure 6.

Figure 6

microRNA-132 induces temozolomide resistance and promotes formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 (TUSC3) in glioblastoma.